Integra Lifesciences Holdings (IART) Inventory (2009 - 2026)

Integra Lifesciences Holdings (IART) has 18 years of Inventory data on file, last reported at $495.0 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory rose 11.14% year-over-year to $495.0 million; the trailing twelve-month figure through Mar 2026 stood at $495.0 million (up 11.14% YoY), and the FY2025 full-year result was $492.7 million, up 14.83% from the prior year.
• Inventory was little changed at $495.0 million in Q1 2026, from $492.7 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $495.0 million in Q1 2026 to a low of $311.1 million in Q3 2022.
• A 5-year average of $401.4 million and a median of $403.4 million in 2024 frame the typical range for Inventory.
• Across the five-year window, Inventory declined 4.92% in 2022 and grew 20.03% in 2023, its largest moves.
• Tracing IART's Inventory over 5 years: stood at $324.6 million in 2022, then gained by 20.03% to $389.6 million in 2023, then advanced by 10.13% to $429.1 million in 2024, then climbed by 14.83% to $492.7 million in 2025, then climbed by 0.47% to $495.0 million in 2026.
• Business Quant data shows IART's Inventory at $495.0 million in Q1 2026, $492.7 million in Q4 2025, and $489.1 million in Q3 2025.